---
document_datetime: 2024-10-21 10:59:12
document_pages: 14
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/amyvid-epar-procedural-steps-taken-scientific-information-after-authorisation-archived_en.pdf
document_name: amyvid-epar-procedural-steps-taken-scientific-information-after-authorisation-archived_en.pdf
version: success
processing_time: 8.0080648
conversion_datetime: 2026-01-17 13:41:39.296504
docling_version:
  docling-serve: 1.10.0
  docling-jobkit: 1.8.1
  docling: 2.68.0
  docling-core: 2.59.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.3
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Amyvid

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                       | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0047/G            | This was an application for a group of variations. B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where | 18/10/2024                          |                                             | Annex II and Labelling           |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | batch control/testing takes place B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.c.1.a - Change in immediate packaging of the AS - Qualitative and/or quantitative composition A.7 - Administrative change - Deletion of manufacturing sites   |            |     |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IB/0048/G | This was an application for a group of variations. B.I.z - Quality change - Active substance - Other variation B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter)                                                                                                                                                                                                                                                                                                                                                   | 19/08/2024 | n/a |
| IA/0045   | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 08/09/2023 | n/a |

<div style=\"page-break-after: always\"></div>

| IB/0043/G           | This was an application for a group of variations. B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier B.II.e.7.b - Change in supplier of packaging   | 01/08/2023   | n/a        |                                  |                                   |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|-----------------------------------|
| PSUSA/10032 /202204 | Periodic Safety Update EU Single assessment - florbetapir (18f)                                                                                                                                                                              | 01/12/2022   | n/a        |                                  | PRAC Recommendation - maintenance |
| IA/0041             | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                | 10/03/2021   | 09/12/2021 | Annex II, Labelling and PL       |                                   |
| IB/0040/G           | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                              | 09/12/2020   | 09/12/2021 | SmPC, Annex II, Labelling and PL |                                   |

<div style=\"page-break-after: always\"></div>

| IB/0039/G   | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data   | 12/10/2020   | n/a   |
|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|
| IB/0038/G   | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.7 - Administrative change - Deletion of manufacturing sites                                                                                                            | 12/08/2020   | n/a   |

<div style=\"page-break-after: always\"></div>

|                     | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.c.1.c - Change in the specification parameters and/or limits of an excipient - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.II.e.3.b - Change in test procedure for the immediate packaging of the finished product - Other changes to a test procedure (including replacement   |            |     |                                   |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| PSUSA/10032 /201904 | Periodic Safety Update EU Single assessment - florbetapir (18f)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 31/10/2019 | n/a | PRAC Recommendation - maintenance |
| PSUSA/10032 /201804 | Periodic Safety Update EU Single assessment - florbetapir (18f)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 31/10/2018 | n/a | PRAC Recommendation - maintenance |
| IAIN/0036           | B.I.a.1.a - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 12/07/2018 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

|           | manufacturer is part of the same group as the currently approved                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |            |            |                        | proposed pharmaceutical manufacturer   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|----------------------------------------|
| IB/0034/G | This was an application for a group of variations. B.II.b.1.f - Replacement or addition of a manufacturing site for part or all of the manufacturing process of the FP - Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically manufactured) excluding biological/ immunological medicinal products B.II.b.2.c.2 - Change to importer, batch release arrangements and quality control testing of the FP - | 04/06/2018 | 18/12/2018 | Annex II and Labelling | Including batch control/testing        |
| II/0029   | C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                                                                                                                                                                                                                                                                                                                            | 17/05/2018 | 18/12/2018 | SmPC                   |                                        |
| IB/0033   | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                                                                                                                                                                                | 24/04/2018 | n/a        |                        |                                        |
| IB/0032/G | This was an application for a group of variations. B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.b.2.a - Change in test procedure for AS or                                                                                                                                                                                                                                                                                                                       | 21/03/2018 | n/a        |                        |                                        |

<div style=\"page-break-after: always\"></div>

|                     | changes to an approved test procedure B.I.c.1.a - Change in immediate packaging of the AS - Qualitative and/or quantitative composition B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data B.I.d.1.c - Stability of AS - Change in the re-test period/storage period or storage conditions - Change to an approved stability protocol   |            |            |                        |                                   |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------|
| IB/0028/G           | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation                                                                                                                                                                    | 11/01/2018 | n/a        |                        |                                   |
| IA/0031             | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                               | 21/12/2017 | 18/12/2018 | Annex II and Labelling |                                   |
| IA/0030             | B.II.e.3.b - Change in test procedure for the immediate packaging of the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                                                                                                                                           | 21/12/2017 | n/a        |                        |                                   |
| PSUSA/10032 /201704 | Periodic Safety Update EU Single assessment - florbetapir (18f)                                                                                                                                                                                                                                                                                                                                                                                             | 26/10/2017 | n/a        |                        | PRAC Recommendation - maintenance |

<div style=\"page-break-after: always\"></div>

| R/0026    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 20/07/2017   | 21/09/2017   | SmPC, Labelling and PL       | Based on the review of data on quality, safety, and efficacy, the CHMP considered that the benefit-risk balance of Amyvid in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity.   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0024/G | This was an application for a group of variations. A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release B.II.b.1.f - Replacement or addition of a manufacturing site for part or all of the manufacturing process of the FP - Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically manufactured) excluding biological/ immunological medicinal products B.II.b.2.c.2 - Change to importer, batch release arrangements and quality control testing of the FP - Including batch control/testing | 22/03/2017   | 21/09/2017   | Annex II, Labelling and PL   |                                                                                                                                                                                                                                                                         |
| IA/0025   | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 15/03/2017   | n/a          |                              |                                                                                                                                                                                                                                                                         |
| II/0022   | Update of sections 4.4 and 5.1 of the SmPC in order to introduce quantitative read as an adjunct to visual read of florbetapir (18F) PET scans. In addition, the Marketing authorisation holder (MAH) took the opportunity bring the PI in line with                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 15/12/2016   | 06/02/2017   | SmPC, Annex II and Labelling | Based on the data from studies QP01 and QP02, the MAH proposes changes to the SmPC, reflecting the following key principles: • Addition of results and conclusions from studies QP01 and QP02 indicating that quantitation when used as                                 |

<div style=\"page-break-after: always\"></div>

|                     | the latest QRD template version 10.0. The updated RMP version 2.2 has been submitted C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                                           |            |     | an adjunct to the qualitative interpretation may improve readers' accuracy. • The use of quantitation is proposed to be optional because not all PET users may have access to software with quantitation capabilities suitable for use with the proposed method, and since the approved visual read method has been demonstrated to have sufficient accuracy. • The MAH proposes not to limit the use of quantitative software packages to those software packages used in the QP01 and QP02 trials. Indeed, the software packages used in these trials may not be available in all EU countries and new innovations in software packages may become available. Therefore, the proposed SmPC wording allows for broader quantitative software access and preserves the possibility of future innovations in the quantitative software. The quantitative reader training program will specify minimum recommended elements for quantitative software to be used as an adjunct quantitation   |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/10032 /201604 | Periodic Safety Update EU Single assessment - florbetapir (18f)                                                                                                                                                                                                                                                                                  | 27/10/2016 | n/a | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| IB/0023/G           | This was an application for a group of variations. B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.II.c.1.z - Change in the specification parameters | 21/10/2016 | n/a |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

<div style=\"page-break-after: always\"></div>

|                     | and/or limits of an excipient - Other variation                                                                                                                                                                                                                                                                                                                        |            |            |                        |                                   |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------|
| PSUSA/10032 /201510 | Periodic Safety Update EU Single assessment - florbetapir (18f)                                                                                                                                                                                                                                                                                                        | 14/04/2016 | n/a        |                        | PRAC Recommendation - maintenance |
| IG/0662             | A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                                                                                                                                             | 23/02/2016 | 06/02/2017 | SmPC, Labelling and PL |                                   |
| PSUSA/10032 /201504 | Periodic Safety Update EU Single assessment - florbetapir (18f)                                                                                                                                                                                                                                                                                                        | 06/11/2015 | n/a        |                        | PRAC Recommendation - maintenance |
| IAIN/0018/G         | This was an application for a group of variations. A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release A.7 - Administrative change - Deletion of manufacturing sites | 14/08/2015 | 10/12/2015 | Annex II and Labelling |                                   |
| N/0016              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                       | 16/06/2015 | 10/12/2015 | Labelling and PL       |                                   |
| IA/0015             | A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient                                                                                                                           | 20/05/2015 | n/a        |                        |                                   |

<div style=\"page-break-after: always\"></div>

| IB/0014/G           | This was an application for a group of variations. B.II.b.1.f - Replacement or addition of a manufacturing site for part or all of the manufacturing process of the FP - Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically manufactured) excluding biological/ immunological medicinal products B.II.b.2.c.2 - Change to importer, batch release arrangements and quality control testing of the FP - Including batch control/testing   | 05/05/2015   | 10/12/2015   | Annex II, Labelling and PL       |                                   |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|----------------------------------|-----------------------------------|
| PSUSA/10032 /201410 | Periodic Safety Update EU Single assessment - florbetapir (18f)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 10/04/2015   | n/a          |                                  | PRAC Recommendation - maintenance |
| IB/0012/G           | This was an application for a group of variations. B.II.b.1.f - Replacement or addition of a manufacturing site for part or all of the manufacturing process of the FP - Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically manufactured) excluding biological/ immunological medicinal products B.II.b.2.c.2 - Change to importer, batch release arrangements and quality control testing of the FP - Including batch control/testing   | 22/12/2014   | 10/12/2015   | SmPC, Annex II, Labelling and PL |                                   |

<div style=\"page-break-after: always\"></div>

| IB/0010/G   | This was an application for a group of variations. B.II.b.1.f - Replacement or addition of a manufacturing site for part or all of the manufacturing process of the FP - Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically manufactured) excluding biological/ immunological medicinal products B.II.b.2.c.2 - Change to importer, batch release arrangements and quality control testing of the FP - Including batch control/testing B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place   | 29/10/2014   | n/a        |                            |                                   |
|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------|-----------------------------------|
| PSUV/0009   | Periodic Safety Update                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 09/10/2014   | n/a        |                            | PRAC Recommendation - maintenance |
| IA/0008     | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 15/05/2014   | n/a        |                            |                                   |
| PSUV/0007   | Periodic Safety Update                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 08/05/2014   | n/a        |                            | PRAC Recommendation - maintenance |
| IB/0006/G   | This was an application for a group of variations. B.II.b.1.f - Replacement or addition of a manufacturing site for part or all of the manufacturing process of the FP - Site where any manufacturing operation(s) take place, except batch                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 18/10/2013   | 27/06/2014 | Annex II, Labelling and PL |                                   |

<div style=\"page-break-after: always\"></div>

|           | and secondary packaging, for medicinal products (including those that are manufactured) excluding biological/ medicinal products - Change to batch release arrangements quality control testing of the FP - Including batch                                                                                                                                                                                                                                                                                                                        |            |            |                            | release, batch control, sterile aseptically immunological B.II.b.2.b.2 and control/testing   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------|----------------------------------------------------------------------------------------------|
| IB/0005/G | This was an application for a group of variations. B.II.b.1.f - Replacement or addition of a manufacturing site for part or all of the manufacturing process of the FP - Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically manufactured) excluding biological/ immunological medicinal products B.II.b.2.b.2 - Change to batch release arrangements and quality control testing of the FP - Including batch | 18/10/2013 | 27/06/2014 | Annex II, Labelling and PL | control/testing                                                                              |
|           | This was an application for a group of variations. B.II.b.1.f - Replacement or addition of a manufacturing site for part or all of the manufacturing process of the FP - Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically manufactured) excluding biological/ immunological medicinal products                                                                                                             | 18/10/2013 | 27/06/2014 | Annex II, Labelling and PL | IB/0004/G                                                                                    |

<div style=\"page-break-after: always\"></div>

|         | B.II.b.2.b.2 - Change to batch release arrangements and quality control testing of the FP - Including batch control/testing B.II.b.2.a - Change to batch release arrangements and quality control testing of the FP - Replacement or addition of a site where batch control/testing takes place   |            |            |                                  |                                                                                                                                                                                                |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0002 | Update of section 4.8 of the SmPC and section 4 of the PL to include injection site reactions. C.I.4 - Variations related to significant modifications of the SPC due in particular to new quality, pre- clinical, clinical or pharmacovigilance data                                             | 25/07/2013 | 27/06/2014 | SmPC, Annex II, Labelling and PL | The undesirables' effects section of the SmPC and Package Leaflet has been updated to include the occurrence of injection site reaction (rash, bleeding or pain where the injection is given). |
| IG/0321 | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                    | 17/07/2013 | n/a        |                                  |                                                                                                                                                                                                |
| N/0001  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                  | 08/04/2013 | 27/06/2014 | Labelling                        |                                                                                                                                                                                                |